Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography
about
Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.Oncologic positron emission tomography: a surgical perspective.Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer.FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.Utility of fusion CT-PET in the diagnosis of small pancreatic carcinoma.18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.Acute portal vein thrombosis: an important mimic of malignancy on FDG PET/CTChronic pancreatitis and pancreatic carcinoma.Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinomaApplication of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly.Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.A review of applications of metabolomics in cancer.The current role of PET-CT in the characterization of hepatobiliary malignancies.Metabolic signatures of malignant and non-malignant mass-forming lesions in the periampulla and pancreas in FDG PET/CT scan: an atlas with pathologic correlation.Imaging modalities for characterising focal pancreatic lesions.Endoscopic ultrasonography for pancreatic cancer: current and future perspectives.Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging.Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses?The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.The usefulness of (18)F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with (18)F-FDG PET/CT.Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis.Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection.Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumoursFDG-PET scanning in the diagnosis of gastrointestinal cancers
P2860
Q28362865-24513C4B-947F-4E39-BEBB-6B694DA14F4CQ33611851-DF77E049-9948-48F6-984C-3B7B23AA01A1Q33945401-D530AE28-CD0B-4FB7-99A3-72B22F9D900FQ34072096-7F2DCB3B-41A5-4CB9-BD72-EDCFA2F8DC17Q34277286-9E3C9661-7DC7-4871-A006-2B4B80A78C4FQ34901401-4D0441DB-DD3C-4715-872F-E63C1A02A5ADQ35045552-1BE051E4-5157-4FEE-9ED9-99A6F94D13B5Q35127213-C59DD6A8-9CC3-4635-A4FC-2253C62A3FD3Q35295894-B67D38DE-6240-442F-A66D-EBF5130ADDEAQ36728049-1DAE80D3-4EDB-4DA6-B865-5AFFBBF70C24Q36924872-B6006886-37F5-4556-9F62-3F814B0CBCE1Q37305985-D8A86736-E66B-42CB-A61C-9B9C9F9D3DDEQ37385077-56D8F749-1FBE-401D-A592-BA9FFFDE1575Q37512830-9F758306-CB0D-4CC8-9DB1-6B62D188D9D7Q37546832-BEB0683A-F676-4B6A-87B5-53CCC1BCE544Q38258220-1E5B0225-A57F-4F35-B459-BA8B4116FB58Q38834240-DA7A9931-637E-4377-A6C3-9260C454091BQ39408683-98F78AC9-B816-4784-8D2C-B4039E97D553Q39429337-7DBE09B5-040F-491C-BAA9-37A95D42404EQ42062348-B9B70073-5716-40DB-BFC2-B5C3F89BAE97Q42329676-E6CA2851-2B33-4EE0-89EC-73B153DB8417Q45150828-2E877597-0A11-4C97-B60C-89EF8BDFE9CDQ49391836-2AAA49DB-783F-4A66-BB88-11DC8B9EFFE9Q53113401-F950C61D-8DB4-4EC1-B3D7-E8D070EB75CAQ53117802-28B610C2-1184-40BC-BF76-8809A4E521BDQ53270915-1E11E9B7-9AE6-4ED8-B9E1-90E73ADBC66FQ57767529-0228150B-8A7D-44D1-AADD-D532D47C243CQ57779674-43405460-97F1-4A7A-B06E-3BE99BE0E26F
P2860
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Diagnosis of pancreatic cancer ...... e positron emission tomography
@ast
Diagnosis of pancreatic cancer ...... e positron emission tomography
@en
Diagnosis of pancreatic cancer ...... e positron emission tomography
@nl
type
label
Diagnosis of pancreatic cancer ...... e positron emission tomography
@ast
Diagnosis of pancreatic cancer ...... e positron emission tomography
@en
Diagnosis of pancreatic cancer ...... e positron emission tomography
@nl
prefLabel
Diagnosis of pancreatic cancer ...... e positron emission tomography
@ast
Diagnosis of pancreatic cancer ...... e positron emission tomography
@en
Diagnosis of pancreatic cancer ...... e positron emission tomography
@nl
P2093
P2860
P356
P1433
P1476
Diagnosis of pancreatic cancer ...... e positron emission tomography
@en
P2093
P2860
P304
P356
10.1136/GUT.36.5.771
P407
P577
1995-05-01T00:00:00Z